Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

An effective immune system depends upon a network of molecular interactions that detect and respond to pathogens and altered self. T cells are central to mammalian immunity, harnessing their T cell receptors (TCR) to discriminate between self and foreign or altered peptides presented on major histocompatibility complexes (pMHC). The TCR repertoire is dwarfed by a much greater landscape of foreign pMHC, requiring each TCR to recognise numerous peptides for sufficient immunological surveillance, a concept known as “cross-reactivity”. Important aspects of the molecular mechanisms underlying TCR cross-reactivity are unknown, prohibiting the accurate mapping of TCR to pMHC and vice versa. This imposes significant limitations on the applicability and safety of TCR-based therapies. The work described in this thesis seeks to characterise TCR cross-reactivity by probing TCR/pMHC interactions at scale using diverse pMHC yeast display libraries together with functional and biophysical assays. Leveraging the affinity-enhanced a3a TCR with its established cross-reactivity for self-antigens as a case study, the capacity to “de-engineer” cross-reactivity is explored by systematically reverting the engineered amino acid substitutions to the original TCR sequence. Characterisation of these novel TCR variants confirms that the cross-reactivity of the a3a TCR is driven by greater contributions of TCR:MHC relative to TCR:peptide contacts and further exacerbated by a peptide binding “hotspot”. Combining pMHC yeast display libraries with computational prediction pipelines characterises the agonist peptide landscapes of the TCR variants and identifies sequences displaying minimal cross-reactivity. Steps are also taken toward investigating the possibility of tuning T cell sensitivity without manipulating the extracellular TCR by altering the intracellular signalling domains. Lastly, in an attempt to establish an alternative to the classic X-ray crystallographic methods used to describe the structural components of the TCR/pMHC interaction, the structures of two physiological TCR/pMHC complexes are determined by cryo-EM.

Type

Thesis / Dissertation

Publication Date

02/07/2025